What analysts say:
- Buy, sell, or hold?: Analysts think investors should stand pat on NCI with seven of 10 analysts rating it hold. Analysts don't like NCI as much as competitor Dynamics Research overall. Two out of five analysts rate Dynamics Research a buy compared to zero of 10 for NCI.
- Revenue forecasts: On average, analysts predict $116.8 million in revenue this quarter. That would represent a decline of 31.7% from the year-ago quarter.
- Wall Street earnings expectations: The average analyst estimate is earnings of $0.06 per share. Estimates range from $0.01 to $0.15.
What our community says:
CAPS All-Stars are enthusiastically backing the stock, with 90% awarding it an "outperform" rating. The greater community concurs with the All-Stars, as 94.8% give it a rating of "outperform." Fools have embraced NCI, though the message boards have been quiet lately with only 54 posts in the past 30 days. NCI's bearish CAPS rating of two out of five stars falls short of the Fool community sentiment.
NCI's income has fallen year over year by an average of 16.2% over the past five quarters. A year-over-year revenue decrease last quarter snaps a streak of three consecutive quarters of revenue increases.
For all our NCI-specific analysis, including earnings and beyond, add NCI to My Watchlist.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.Earnings estimates provided by Zacks.